Skip to main content
. 2017 Nov 9;15(1):998–1006. doi: 10.3892/ol.2017.7386

Figure 5.

Figure 5.

Kaplan-Meier survival analysis according to the CD163 immunohistochemical expression. (A) Correlation of overall survival (OS) with CD163 levels according to a four-category (0, 1, 2, 3) scoring system in WHO III grade glioma patients. (B) Correlation of OS with the IDH gene status and the CD163 expression (0=low, 1=high) in 60 patients of WHO II–III grade gliomas. The log-rank test was performed to determine statistical significance, and P<0.05 was considered significant. CD, luster of differentiation; M, mutated; WT, wildtype; WHO, World Health Organization; IDH, isocitrate dehydrogenase.